Multiplex PCR pathogen detection in two severely burned patients with suspected septicemia

Journal of Burn Care and Research

Volumn 32, Issue 6, 2011, Pages

  Tran, Nam K ^a   Greenhalgh, David G ^a   Palmieri, Tina L ^a   Kost, Gerald J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; MEROPENEM; POSACONAZOLE; TOBRAMYCIN; VORICONAZOLE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BLOOD CLOTTING DISORDER; BLOOD CULTURE; BURN; CASE REPORT; DEBRIDEMENT; DISSEMINATED INTRAVASCULAR CLOTTING; ESCHERICHIA COLI; FASCIOTOMY; FLUID RESUSCITATION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; HYPOTENSION; LABORATORY TEST; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; SEPTICEMIA; SKIN GRAFT; SPUTUM CULTURE; TRACHEAL ASPIRATION PROCEDURE; URINE CULTURE; WOUND CARE;

ADULT; ANTI-BACTERIAL AGENTS; BURNS; CEFTRIAXONE; DISSEMINATED INTRAVASCULAR COAGULATION; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FATAL OUTCOME; HUMANS; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEPSIS; SEVERITY OF ILLNESS INDEX; THIENAMYCINS; TIME FACTORS; YOUNG ADULT;

EID: 81155139734     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e318231c140     Document Type: Article

References (18)

1. Greenhalgh DG, Saffle JR, Holmes JH IV, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 2007;28:776-90.
2. Sharma BR, Harish D, Singh VP, Bangar S. Septicemia as a cause of death in burns: autopsy study. Burns 2006;32: 545-9.
3. Hansbrough JF, Zapata-Sirvent RL, Peterson VM. Immunomodulation following burn injury. Surg Clin North Am 1987;67:69-92.
4. Apostolopolou E, Katsaris G, Katostaras T. Risk factors for noso-comial bloodstream infections. Br J Nurs 2003;12:720-6.
5. Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg 2006;141:1132-40.
6. Polk HC Jr, King N, Weiner LJ. Modern trends in care of the burn patient. Dis Mon 1973:1-39.
7. Passerini R, Riggio D, Radice D, et al. Interference of antibiotic therapy on blood cultures time-to-positivity: analysis of a 5-year experience in an oncological hospital. Eur J Clin Microbiol Infect Dis 2009;28:95-8.
8. ARUP Laboratory Antimicrobial Susceptibility-MIC/MBC Guide; available from Error! Hyperlink reference not valid. accessed August 29, 2010.
9. Yanagihara K, Kitagawa Y, Tomonaga M, et al. Evaluation of pathogen detection from clinical samples by real-time poly-merase chain reaction using sepsis pathogen DNA detection kit. Crit Care 2010;14:R159.
10. Lehmann LE, Hunfeld KP, Emrich T, et al. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008;197:313-24.
11. Ryan CM, Schoenfeld DA, Thorpe WP, et al. Objective estimates of the probability of death from burn injuries. N Eng J Med 1998;338:362-6.
12. Sheridan RL. Sepsis in pediatric burn patients. Pediatr Crit Care Med 2005;6:S112-9.
13. Cheewatrakoolpong B, Steffen EK, Brown RD, Berg RD. Kinetic analysis of bacterial clearance in mice using ESTRIP and KINET microcomputer programs. J Immunol Methods 1983;58:375-81.
14. Chung HM, Cartwright MM, Bortz DM, Jackson TL, Younger JG. Dynamical system analysis of Staphylococcus epidermidis bloodstream infection. Shock 2008;30: 518-26.
15. Flayhart D, Borek AP, Wakefield T, Dick J, Carroll KC. Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics. J Clin Microbiol 2007;45:816-21.
16. Gando S, Saitoh D, Ogura H, et al. Natural history of disseminated intravascular coagulation based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med 2008;36: 145-50.
17. Yokochi T, Kusumi A, Kido N, et al. Differential release of smooth-type lipopolysaccharide from Pseudomonas aerugi-nosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide. Antimicrob Agents Chemother 1996;40:2410-2.
18. Pollack M, Taylor NS, Callahan LT III. Exotoxin production by clinical isolates of Pseudomonas aeruginosa. Infect Immun 1977;15:776-80.